SYED AFTAB: Open Payments
NPI 1639119894 · JASPER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 100 payments from 10 companies in 2025. Trend: 2023 $1,569 · 2024 $1,434 · 2025 $1,931
Food & beverage: $1,819Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $398 |
| Alkermes, Inc. | 29 | $246 |
| Lundbeck LLC | 9 | $245 |
| Teva Pharmaceuticals USA, Inc. | 9 | $241 |
| Otsuka America Pharmaceutical, Inc. | 12 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $226 |
| Neurocrine BioSciences, Inc. | 5 | $108 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| ABBVIE INC. | 3 | $81 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
Products named: COBENFY, ABILIFY MAINTENA, ARISTADA, CAPLYTA, REXULTI, UZEDY, INGREZZA, FANAPT.
Industry payments across AL — which companies pay providers there.
